SARS-CoV-2 Envelope antibody (SARS-CoV-2 E) (N-Term) Primary Antibody
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
- Binding Specificity
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
This SARS-CoV-2 Envelope antibody is un-conjugated
ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
- Predicted Reactivity
- Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (100%)
- Affinity chromatography purified via peptide column
Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein.
The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
- Application Notes
- SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody can be used for the detection of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein in ELISA. It will detect 20 ng of free peptide at 1 μg/mL.
- For Research Use only
- 1 mg/mL
- The antibody is supplied in PBS containing 0.02% sodium azide.
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
- 4 °C/-20 °C
- Storage Comment
- The antibody can be stored at 4 ˚ C for three months and -20 ˚ C, stable for up to one year.
- Expiry Date
- 12 months
Magro, Mulvey, Laurence, Sanders, Crowson, Grossman, Harp, Nuovo: "The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series." in: The British journal of dermatology, Vol. 184, Issue 1, pp. 141-150, 2021 (PubMed).
Vojdani, Vojdani, Kharrazian: "Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases." in: Frontiers in immunology, Vol. 11, pp. 617089, 2021 (PubMed).
Magro, Mulvey, Berlin, Nuovo, Salvatore, Harp, Baxter-Stoltzfus, Laurence: "Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases." in: Translational research : the journal of laboratory and clinical medicine, Vol. 220, pp. 1-13, 2020 (PubMed).
Mulvey, Magro, Ma, Nuovo, Baergen: "Analysis of complement deposition and viral RNA in placentas of COVID-19 patients." in: Annals of diagnostic pathology, Vol. 46, pp. 151530, 2020 (PubMed).
Nuovo, Tili, Suster, Matys, Hupp, Magro et al.: "Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG ..." in: Annals of diagnostic pathology, Vol. 48, pp. 151600, 2020 (PubMed).
Yurkovetskiy, Wang, Pascal, Tomkins-Tinch, Nyalile, Wang, Baum, Diehl, Dauphin, Carbone, Veinotte, Egri, Schaffner, Lemieux, Munro, Rafique, Barve, Sabeti, Kyratsous, Dudkina, Shen, Luban: "Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant." in: Cell, Vol. 183, Issue 3, pp. 739-751.e8, 2020 (PubMed).
Schöler, Le-Trilling, Eilbrecht, Mennerich, Anastasiou, Krawczyk, Herrmann, Dittmer, Trilling: "A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds." in: Frontiers in immunology, Vol. 11, pp. 573526, 2020 (PubMed).
Nuovo, Magro, Mikhail: "Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx." in: Annals of diagnostic pathology, Vol. 48, pp. 151565, 2020 (PubMed).
Ventura, Cennamo, Minopoli, Campanile, Censi, Terracciano, Portella, Velotta: "Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs." in: ACS sensors, Vol. 5, Issue 10, pp. 3043-3048, 2020 (PubMed).
- Magro, Mulvey, Laurence, Sanders, Crowson, Grossman, Harp, Nuovo: "The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series." in: The British journal of dermatology, Vol. 184, Issue 1, pp. 141-150, 2021 (PubMed).
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
- Alternative Name
- SARS-CoV-2 Envelope Protein
- envelope protein, E
- Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak. The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.
- Gene ID
- NCBI Accession